[Federal Register Volume 67, Number 96 (Friday, May 17, 2002)]
[Notices]
[Page 35123]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12454]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4), and 552b(6), as 
amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Dates: June 11-12, 2002.
    Open: June 11, 2002, 8:45 a.m. to 4 p.m.
    Agenda: Program reports and presentations: Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: June 11, 2002, 4 p.m. to Recess.
    Agenda: Review of grant applications; Discussion of confidential 
personnel issues.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Bethesda, MD 20892.
    Open: June 12, 2002, 8:45 a.m. to 10:50 a.m.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. 
(301) 496-5147.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Cancer Centers.
    Time: June 11, 2002, 12 p.m. to 1 p.m.
    Agenda: To discuss activities related to the Subcommittee on 
Cancer Centers.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Brian Kimes, Executive Secretary, 
Subcommittee on Cancer Centers, National Cancer Institute, National 
Institutes of Health, 6116 Executive Blvd, Suite 700, Bethesda, MD 
20892, (301) 496-8537.
    Any interested person may file written comments with the 
committee by forwarding the statement of the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.
    Information is also available on the Institute's/Center home 
page: deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancern Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancern 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 13, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-12454 Filed 5-16-02; 8:45 am]
BILLING CODE 4140-01-M